Network-based prediction of drug-target interactions using an arbitrary-order proximity embedded deep forest

Bioinformatics

Volumn 36, Issue 9, 2020, Pages 2805-2812

  Zeng, Xiangxiang ^a   Zhu, Siyi ^b   Hou, Yuan ^c   Zhang, Pengyue ^d   Li, Lang ^d   Li, Jing ^e   Huang, L Frank ^f,g   Lewis, Stephen J ^h   Nussinov, Ruth ^i,j   Cheng, Feixiong ^c,h  

^a HUNAN UNIVERSITY   (China)

^b XIAMEN UNIVERSITY   (China)

^c LERNER RESEARCH INSTITUTE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e Case Western Reserve University   (United States)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^g UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^h CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ NATIONAL CANCER INSTITUTE   (United States)

^j TEL AVIV UNIVERSITY   (Israel)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

DRUG INTERACTION; DRUG REPOSITIONING; FOREST; SOFTWARE;

DRUG INTERACTIONS; DRUG REPOSITIONING; FORESTS; PROTEINS; SOFTWARE;

EID: 85082017701     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btaa010     Document Type: Article

References (55)

1. Apweiler, R. et al. (2004) UniProt: the universal protein knowledgebase. Nucleic Acids Res., 32, D115-119.
2. Bleakley, K. and Yamanishi, Y. (2009) Supervised prediction of drug-target interactions using bipartite local models. Bioinformatics, 25, 2397-2403.
3. Brunetti, M. et al. (2012) Aripiprazole, alcohol and substance abuse: a review. Eur. Rev. Med. Pharmacol. Sci., 16, 1346-1354.
4. Cao, S. et al. (2015) GraRep: learning graph representations with global structural information. In: Proceedings of the 24th ACM International on Conference on Information and Knowledge Management.ACM, Melbourne, Australia, pp. 891-900.
5. Chang, C.-C. and Lin, C.-J. (2011) LIBSVM: a library for support vector machines. ACM Trans. Intell. Syst. Technol., 2, 1-27.
6. Chen, M. et al. (2019) DAKB-GPCRs: an integrated computational platform for drug abuse related GPCRs. J. Chem. Inf. Model., 59, 1283-1289.
7. Cheng, A.C. et al. (2007) Structure-based maximal affinity model predicts small-molecule druggability. Nat. Biotechnol., 25, 71-75.
8. Cheng, F. et al. (2012a) Prediction of chemical-protein interactions network with weighted network-based inference method. PLoS One, 7, e41064.
9. Cheng, F. et al. (2012b) Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput. Biol., 8, e1002503.
10. Cheng, F. et al. (2018) Network-based approach to prediction and population-based validation of in silico drug repurposing. Nat. Commun., 9, 2691.
11. Cheng, F. et al. (2019a) A genome-wide positioning systems network algorithm for in silico drug repurposing. Nat. Commun., 10, 3476.
12. Cheng, F. et al. (2019b) Network-based prediction of drug combinations. Nat. Commun., 10, 1197.
13. Cui, P. et al. (2019) A survey on network embedding. IEEE Trans. Knowl. Data Eng., 31, 833-852.
14. Donald, B.R. (2011) Algorithms in Structural Molecular Biology. MIT Press, Cambridge, MA.
15. Eckart, C. and Young, G. (1936) The approximation of one matrix by another of lower rank. Psychometrika, 1, 211-218.
16. Gaulton, A. et al. (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res., 40, D1100-1107.
17. Gonen, M. (2012) Predicting drug-target interactions from chemical and gen-omic kernels using Bayesian matrix factorization. Bioinformatics, 28, 2304-2310.
18. Haggarty, S.J. et al. (2003) Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays. Chem. Biol., 10, 383-396.
19. He, Z. et al. (2010) Predicting drug-target interaction networks based on functional groups and biological features. PLoS One, 5, e9603.
20. Hernandez-Boussard, T. et al. (2007) The pharmacogenetics and pharmaco-genomics knowledge base: accentuating the knowledge. Nucleic Acids Res., 36, D913-D918.
21. Hoffman, A.S. et al. (1986) Catatonic reaction to accidental haloperidol overdose: an unrecognized drug abuse risk. J. Nerv. Ment. Dis., 174, 428-430.
22. Keiser, M.J. et al. (2007) Relating protein pharmacology by ligand chemistry. Nat. Biotechnol., 25, 197-206.
23. Kuruvilla, F.G. et al. (2002) Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays. Nature, 416, 653-657.
24. Law, V. et al. (2014) DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res., 42, D1091-D1097.
25. LeCun, Y. et al. (2015) Deep learning. Nature, 521, 436-444.
26. Liu, T. et al. (2007) BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res., 35, D198-201.
27. Lo Coco, G. et al. (2019) Group treatment for substance use disorder in adults: a systematic review and meta-analysis of randomized-controlled trials. J. Subst. Abuse Treat., 99, 104-116.
28. Lounkine, E. et al. (2012) Large-scale prediction and testing of drug activity on side-effect targets. Nature, 486, 361-367.
29. Machielsen, M.W. and de Haan, L. (2009) Differences in efficacy on substance abuse between risperidone and clozapine supports the importance of differential modulation of dopaminergic neurotransmission. Psychopharmacol. Bull., 42, 40-52.
30. Mei, J.P. et al. (2013) Drug-target interaction prediction by learning from local information and neighbors. Bioinformatics, 29, 238-245.
31. Mendez, D. et al. (2019) ChEMBL: towards direct deposition of bioassay data. Nucleic Acids Res., 47, D930-D940.
32. Morris, G.M. et al. (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem., 30, 2785-2791.
33. Ohlson, S. (2008) Designing transient binding drugs: a new concept for drug discovery. Drug Discov. Today, 13, 433-439.
34. Pahikkala, T. et al. (2015) Toward more realistic drug-target interaction predictions. Brief. Bioinform., 16, 325-337.
35. Pawson, A.J. et al. (2014) The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucleic Acids Res., 42, D1098-D1106.
36. Perlman, L. et al. (2011) Combining drug and gene similarity measures for drug-target elucidation. J. Comput. Biol., 18, 133-145.
37. Perozzi, B. et al. (2014) DeepWalk: online learning of social representations. In: Proceedings of the 20th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. ACM, New York, NY, USA, pp. 701-710.
38. Rarey, M. et al. (1996) A fast flexible docking method using an incremental construction algorithm. J. Mol. Biol., 261, 470-489.
39. Strang, G. (2006) Linear Algebra and Its Applications, 4th edn. India Edition. ISBN-10: 9788131501726.
40. Swathy, B. and Banerjee, M. (2017) Haloperidol induces pharmacoepigenetic response by modulating miRNA expression, global DNA methylation and expression profiles of methylation maintenance genes and genes involved in neurotransmission in neuronal cells. PLoS One, 12, e0184209.
41. Tang, J. et al. (2015) LINE: large-scale information network embedding. In: Proceedings of the 24th International Conference on World Wide Web. International World Wide Web Conferences Steering Committee, Florence, Italy, pp. 1067-1077.
42. Ursu, O. et al. (2019) DrugCentral 2018: an update. Nucleic Acids Res., 47, D963-D970.
43. van Laarhoven, T. and Marchiori, E. (2013) Predicting drug-target interactions for new drug compounds using a weighted nearest neighbor profile. PLoS One, 8, e66952.
44. Wan, F. et al. (2019) NeoDTI: neural integration of neighbor information from a heterogeneous network for discovering new drug-target interactions. Bioinformatics, 35, 104-111.
45. Wang, J. et al. (2017) Weak-binding molecules are not drugs? Toward a systematic strategy for finding effective weak-binding drugs. Brief. Bioinform., 18, 321-332.
46. Wang, W. et al. (2014) Drug repositioning by integrating target information through a heterogeneous network model. Bioinformatics, 30, 2923-2930.
47. Wei, Z. et al. (2012) A pharmacogenetic study of risperidone on histamine H3 receptor gene (HRH3) in Chinese Han schizophrenia patients. J. Psychopharmacol., 26, 813-818.
48. Wishart, D.S. et al. (2018) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res., 46, D1074-D1082.
49. Xia, Z. et al. (2010) Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces. BMC Syst. Biol., 4(Suppl. 2), S6.
50. Yang, H. et al. (2016) Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information. Nucleic Acids Res., 44, D1069-D1074.
51. Zeng, X. et al. (2020) Target identification among known drugs by deep learning from heterogeneous networks. Chem. Sci. In press. DOI: 10.1039/C9SC04336E.
52. Zhang, Z. et al. (2018) Arbitrary-order proximity preserved network embedding. In: Proceedings of the 24th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. ACM, London, UK, pp. 2778-2786.
53. Zheng, X. et al. (2013) Collaborative matrix factorization with multiple similarities for predicting drug-target interactions. In: Proceedings of the 19th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. ACM, Chicago, IL, USA, pp. 1025-1033.
54. Zhou, Z.-H. and Feng, J. (2017) Deep forest: towards an alternative to deep neural networks. In: Proceedings of the Twenty-sixth International Joint Conference on Artificial Intelligence. South Wharf, Australia, pp. 3553-3559.
55. Zong, N. et al. (2017) Deep mining heterogeneous networks of biomedical linked data to predict novel drug-target associations. Bioinformatics, 33, 2337-2344.